Home / About / Press Releases

Press Releases

Shockwave Medical Announces U.S. Commercial Availability of Lithoplasty® System and Enrollment of First Patient in DISRUPT PAD III Global Clinical Trial

Share this page:
See all press releases

Ready to Make Waves with Shockwave IVL?

Looking for careers? Click here.

connect Connect

We're excited about IVL's potential in aortic stenosis, too!

But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.

MORE ON TAVR ENABLING TRANSFEMORAL ACCESS
SIGN UP FOR UPDATES ON OUR VALVE R&D PROGRAM

Get Crackin' with Shockwave IVL Today

Thanks for contacting us! We will get in touch with you shortly.